Sector consensus Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.38 EUR | -0.75% |
|
-1.30% | -10.27% |
| May. 13 | Spanish stocks - Factors to watch on May 13 | RE |
| May. 09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,240.46 | +1.93% | 28 | |||||||
| 258.59 | -0.2% | 22 | |||||||
| 259.46 | +3.82% | 28 | |||||||
| 359.22 | +7.07% | 18 | |||||||
| 215.99 | +20.73% | 22 | |||||||
| 153.66 | -0.27% | 21 | |||||||
| 316.91 | -1.01% | 24 | |||||||
| 355.66 | -2.19% | 29 | |||||||
| 158.3 | +17.4% | 27 | |||||||
| 29.02 | +19.66% | 26 | |||||||
| 554.56 | +11.69% | 25 | |||||||
| 63 | +8.73% | 24 | |||||||
| 21.17 | +8.03% | 19 | |||||||
| 96.31 | +25.93% | 23 | |||||||
| 10,006.67 | +35.98% | 15 | |||||||
| 54.36 | +7.22% | 18 | |||||||
| 6,106.87 | +13.13% | 15 | |||||||
| 81.21 | +46.04% | 15 | |||||||
| 438.75 | +40.27% | 24 | |||||||
| Average | 1,093.17 | +13.89% | 22 | ||||||
| Weighted average by Cap. | 711.2 | +6.83% | 24 |
Select your edition
All financial news and data tailored to specific country editions
















